Abstract

BackgroundMany protocols for recombinant production of peptides and proteins include secretion into the periplasmic space of Escherichia coli, as they may not properly fold in the cytoplasm. If a signal peptide is not sufficient for translocation, a larger secretion moiety can instead be fused to the gene of interest. However, due to the covalent linkage of the proteins, a protease recognition site needs to be introduced in between, altering the N-terminus of the product. In the current study, we combined the ubiquitin fusion technology, which allows production of authentic peptides and proteins, with secretion by the perpiplasmic protease inhibitor ecotin.ResultsDifferent fusion constructs, composed of ecotin, mouse ubiquitin b and a model peptide, were expressed in E. coli BL21(DE3). The fusion proteins were translocated into the periplasmic space and the ecotin signal peptide was cleaved off. Under the control of the lacUV5 promoter at 24°C we obtained 18 mg periplasmic recombinant protein per gram dry cell weight. However, vigorous expression with the T7 promoter caused outer membrane permeabilization and leakage of the fusion protein into the culture medium. Target peptides were released from hybrid proteins by the deubiquitinating enzyme ubiquitin c-terminal hydrolase-L3 in vitro. MALDI TOF-TOF mass spectroscopy confirmed accurate cleavage.ConclusionThis newly described method represents a useful technique for the production of authentic soluble peptides in the periplasm of E. coli. In addition, larger proteins might also be produced with the current system by the use of ubiquitin specific proteases, which can cleave off larger C-terminal extensions.

Highlights

  • Many protocols for recombinant production of peptides and proteins include secretion into the periplasmic space of Escherichia coli, as they may not properly fold in the cytoplasm

  • Protran BA 83 nitrocellulose membrane was obtained from Whatman, polyvinylidene difluoride (PVDF) membrane from Hybond. mouse antiGroEL monoclonal antibody was purchased from Stressgen Bioreagents, goat anti-Mouse IgG (HRP conjugated) from Invitrogen, anti-Maltose Binding Protein (MBP) monoclonal antibody (HRP conjugated) from New England Biolabs

  • Control expression of ecotin First, we surveyed if Strep-Tag II labeled ecotin could be secreted into the periplasm by conventional expression with the pET system at 37°C

Read more

Summary

Introduction

Many protocols for recombinant production of peptides and proteins include secretion into the periplasmic space of Escherichia coli, as they may not properly fold in the cytoplasm. We combined the ubiquitin fusion technology, which allows production of authentic peptides and proteins, with secretion by the perpiplasmic protease inhibitor ecotin. The ubiquitin moiety enhances fusion protein yield and increases solubility due to intrinsic chaperonin properties [7]. This fusion system allows production of proteins and peptides with an authentic N-terminus by the use of deubiquitinating enzymes (DUB), cleaving the amide bond at the C-terminus of ubiquitin [8]. As E. coli lacks the ubiquitin system, release of target products can be conducted by protease addition [9,10]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call